Mankind Pharma Q3 Results

  • BSE: 543904
  • NSE: MANKIND
  • ISIN: INE634S01028
  • Sector: -
BSE
2,152.4533.00 (1.56%)
Volume19.97 K
Updated: Fri 12 Jul, 2024 | 15:29:46
NSE
2,152.4535.20 (1.66%)
Volume4.95 L
Updated: Fri 12 Jul, 2024 | 15:52:57
Today: 2,104.80
2,158.00
52-Wk: 1,680.50
2,488.65

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Mankind Pharma Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ Comp
    Total Revenue 2,606.962,708.10-3.73%
    Selling/ General/ Admin Expenses Total 568.35571.96-0.63%
    Depreciation/ Amortization 109.7396.4813.72%
    Other Operating Expenses Total 604.51628.63-3.84%
    Total Operating Expense 2,110.182,121.94-0.55%
    Operating Income 496.78586.16-15.25%
    Net Income Before Taxes 562.33640.99-12.27%
    Net Income 453.76501.03-9.43%
    Diluted Normalized EPS 11.3112.49-9.45%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts